Sequenom: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Companies established in 1994]] | [[Category:Companies established in 1994]] | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
<gallery> | |||
File:SEQUENOM LOGO 2C.PNG|Sequenom | |||
</gallery> | |||
Latest revision as of 01:25, 20 February 2025
Sequenom is a pioneer in the field of genetic analysis, specializing in the development of innovative technology and products that aim to enhance the understanding of the human genome. The company was established in 1994 and is headquartered in San Diego, California. Sequenom's primary business focus is on prenatal care, particularly the development of non-invasive prenatal testing (NIPT) to detect chromosomal abnormalities in fetuses.
History[edit]
Sequenom was founded in 1994 by a group of scientists who were interested in exploring the potential of the human genome. The company initially focused on the development of MassARRAY technology, a high-performance DNA analysis platform. This technology was designed to provide researchers with a cost-effective and scalable method for genotyping and gene expression analysis.
In 2011, Sequenom launched the MaterniT21 PLUS test, the first commercially available non-invasive prenatal test (NIPT) for detecting chromosomal abnormalities in fetuses. This test marked a significant milestone in prenatal care, offering a safer and more accurate alternative to invasive diagnostic procedures.
Products and Services[edit]
Sequenom's product portfolio is primarily focused on prenatal care. The company's flagship product, the MaterniT21 PLUS test, uses advanced sequencing technology to analyze fetal DNA in maternal blood to detect the presence of certain chromosomal abnormalities.
In addition to the MaterniT21 PLUS test, Sequenom also offers the HerediT UNIVERSAL test, a comprehensive carrier screening test designed to identify couples at risk of passing on genetic disorders to their children.
Research and Development[edit]
Sequenom's research and development efforts are focused on the continued improvement and expansion of its product portfolio. The company is committed to advancing the field of genetic analysis and prenatal care through the development of innovative technologies and products.
See Also[edit]
References[edit]
<references />
External Links[edit]
-
Sequenom
